References
- Melter O, Radojevic B. Small colony variants of Staphylococcus aureus—review. Folia Microbiol 2010;55:548–58.
- Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006;4:295–305.
- Wellinghausen N, Chatterjee I, Berger A, Niederfuehr A, Proctor RA, Kahl BC. Characterization of clinical Enterococcus faecalis small-colony variants. J Clin Microbiol 2009;47:2802–11.
- Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995;20:95–102.
- von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept—the role of staphylococcal SCVs in persistent infections. Injury 2006;37(Suppl):S26–33.
- Baddour LM, Christensen GD. Prosthetic valve endocarditis due to small-colony staphylococcal variants. Rev Infect Dis 1987;9:1168–74.
- Gomez-Gonzalez C, Acosta J, Villa J, Barrado L, Sanz F, Orellana MA, et al. Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus. J Clin Microbiol 2010;48:2878–84.
- Maduka-Ezeh A, Seville MT, Kusne S, Vikram HR, Blair JE, Greenwood-Quaintance K, et al. Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection. J Clin Microbiol 2012;50:1102–5.
- Seifert H, Wisplinghoff H, Schnabel P, von Eiff C. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg Infect Dis 2003;9: 1316–8.
- Tumbarello M, Pelargonio G, Trecarichi EM, Narducci ML, Fiori B, Bellocci F, et al. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants. Clin Infect Dis 2012;54:1516–7.
- Svec P, Novakova D, Zackova L, Kukletova M, Sedlacek I. Evaluation of (GTG)5-PCR for rapid identification of Streptococcus mutans. Antonie Van Leeuwenhoek 2008; 94:573–9.
- van de Rijn I, Kessler RE. Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun 1980;27:444–8.
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30: 633–8.
- Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. Circulation 2005;111:e394–434.
- Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369–413.
- Miller MH, Wexler MA, Steigbigel NH. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother 1978;14:336–43.
- Pelletier LL Jr, Richardson M, Feist M. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J Lab Clin Med 1979;94:324–34.
- Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD, et al.; Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012;67:269–89.